 NEWTOWN, Pa., Jan. 05, 2021 GLOBE NEWSWIRE -- Helius Medical Technologies, Inc. Nasdaq:HSDT TSX:HSM Helius or the Company, a neurotech company focused on neurological wellness, is issuing this news release in light of unusual trading activity related to the shares of Class A Common Stock of Helius the Shares on the Toronto Stock Exchange and The Nasdaq Capital Market. In view of such activity, The Nasdaq Capital Market and the Investment Industry Regulatory Organization of Canada IIROC on behalf of the Toronto Stock Exchange contacted the Company in accordance with their usual practice. While Helius does not normally comment on market activity, Helius confirms that it is not aware of any undisclosed material change in the business, operations or affairs of Helius that would account for the recent increase in trading activity, and related increase in trading price, of the Shares on the Toronto Stock Exchange and The Nasdaq Capital Market. Helius notes that this afternoon it is first making available an investor presentation, by furnishing the slides on a Current Report on Form 8-K, in connection with its planned participation at investor conferences in January, which conference participation was announced by press release on January 4, 2021. 